Tipranavir, a Non‐Peptidic Protease Inhibitor for Multi‐Drug Resistant HIV

作者: Suvit Thaisrivongs , Joseph W. Strohbach , Steve R. Turner

DOI: 10.1002/9783527630035.CH18

关键词: VirologyReverse-transcriptase inhibitorTipranavirMulti drug resistantHuman immunodeficiency virus (HIV)Aspartate proteaseProtease inhibitor (biology)Renin inhibitorChemistry

摘要:

参考文章(38)
Hiroaki Mitsuya, Kenji Maeda, Debananda Das, Arun K. Ghosh, Development of protease inhibitors and the fight with drug-resistant HIV-1 variants. Advances in pharmacology. ,vol. 56, pp. 169- 197 ,(2008) , 10.1016/S1054-3589(07)56006-0
Miles Congreve, Christopher W. Murray, Robin Carr, David C. Rees, Chapter 28 Fragment-Based Lead Discovery Annual Reports in Medicinal Chemistry Volume 42. ,vol. 42, pp. 431- 448 ,(2007) , 10.1016/S0065-7743(07)42028-0
S M Poppe, D E Slade, K T Chong, R R Hinshaw, P J Pagano, M Markowitz, D D Ho, H Mo, R R Gorman, T J Dueweke, S Thaisrivongs, W G Tarpley, Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor. Antimicrobial Agents and Chemotherapy. ,vol. 41, pp. 1058- 1063 ,(1997) , 10.1128/AAC.41.5.1058
Alfredo G. Tomasselli, Robert L. Heinrikson, Targeting the HIV-protease in AIDS therapy: a current clinical perspective. Biochimica et Biophysica Acta. ,vol. 1477, pp. 189- 214 ,(2000) , 10.1016/S0167-4838(99)00273-3
J MARTINEZCAJAS, M WAINBERG, Protease inhibitor resistance in HIV-infected patients: molecular and clinical perspectives. Antiviral Research. ,vol. 76, pp. 203- 221 ,(2007) , 10.1016/J.ANTIVIRAL.2007.06.010
Brendan A Larder, Kurt Hertogs, Stuart Bloor, Ch. van den Eynde, Wanda DeCian, Yenyun Wang, William W Freimuth, Gary Tarpley, Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples. AIDS. ,vol. 14, pp. 1943- 1948 ,(2000) , 10.1097/00002030-200009080-00009
L N Martin, K F Soike, M Murphey-Corb, R P Bohm, E D Roberts, T J Kakuk, S Thaisrivongs, T J Vidmar, M J Ruwart, S R Davio, Effects of U-75875, a peptidomimetic inhibitor of retroviral proteases, on simian immunodeficiency virus infection in rhesus monkeys. Antimicrobial Agents and Chemotherapy. ,vol. 38, pp. 1277- 1283 ,(1994) , 10.1128/AAC.38.6.1277
John Randolph, David DeGoey, Peptidomimetic Inhibitors of HIV Protease Current Topics in Medicinal Chemistry. ,vol. 4, pp. 1079- 1095 ,(2004) , 10.2174/1568026043388330
Miles Congreve, Robin Carr, Chris Murray, Harren Jhoti, A 'rule of three' for fragment-based lead discovery? Drug Discovery Today. ,vol. 8, pp. 876- 877 ,(2003) , 10.1016/S1359-6446(03)02831-9
Stefano Rusconi, Simona La Seta Catamancio, Paola Citterio, Semir Kurtagic, Michela Violin, Claudia Balotta, Mauro Moroni, Massimo Galli, Antonella d'Arminio-Monforte, Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors Antimicrobial Agents and Chemotherapy. ,vol. 44, pp. 1328- 1332 ,(2000) , 10.1128/AAC.44.5.1328-1332.2000